Impact of isoflurane on malignant capability of ovarian cancer in vitro
- 1 May 2015
- journal article
- Published by Elsevier BV in British Journal of Anaesthesia
- Vol. 114 (5), 831-839
- https://doi.org/10.1093/bja/aeu408
Abstract
Metastatic recurrence of ovarian cancer is the foremost cause of postoperative mortality. With recent research indicating that inhalation of anaesthetics may influence cancer cell behaviour, this study investigated the effects of isoflurane on the expression of tumorigenic markers and proliferative capacity in ovarian cancer cells. Ovarian cancer (SK-OV3) cells were cultured and then exposed to 2% isoflurane for 2 h. The expression of markers involved in cell proliferation, angiogenesis, and migration were assessed up to 24 h after treatment using immunofluorescence staining, western blotting, and flow cytometry. The effects of isoflurane on in vitro angiogenesis and migration were also determined. Isoflurane exposure significantly increased insulin-like growth factor (IGF)-1 and IGF-1R expression, cell cycle progression, and cell proliferation in SK-OV3 cells. Increased expression of the angiogenic markers vascular endothelial growth factor (VEGF) by 56% (P<0.05) and angiopoietin-1 by 62% (P<0.05) was also observed 24 h after isoflurane exposure together with an enhanced in vitro angiogenesis. Cell migration was significantly increased after exposure to isoflurane together with increased production of both matrix metalloproteinases 2 and 9 (both P<0.05) by almost five-fold relative to control. These effects were abolished when IGF-1R signalling was blocked either by neutralizing antibody or by small interfering RNA. Our data indicate that isoflurane increases the malignant potential of ovarian cancer cells through the up-regulation of markers associated with the cell cycle, proliferation, and angiogenesis. This study warrants further investigations.Keywords
This publication has 32 references indexed in Scilit:
- Early treatment with xenon protects against the cold ischemia associated with chronic allograft nephropathy in ratsKidney International, 2014
- Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis?British Journal of Anaesthesia, 2012
- Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angiopreventionCarcinogenesis: Integrative Cancer Research, 2011
- Cancer recurrence after surgery: Direct and indirect effects of anesthetic agents*International Journal of Cancer, 2011
- Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysisBritish Journal of Anaesthesia, 2011
- Effect of anaesthetic technique and other perioperative factors on cancer recurrenceBritish Journal of Anaesthesia, 2010
- Notch Signaling Pathway in Ovarian CancerInternational Journal of Gynecologic Cancer, 2009
- Anesthetic Technique for Radical Prostatectomy Surgery Affects Cancer RecurrenceAnesthesiology, 2008
- Can Anesthetic Technique for Primary Breast Cancer Surgery Affect Recurrence or Metastasis?Anesthesiology, 2006
- Temperature Dependence of the Potency of Volatile General AnestheticsAnesthesiology, 1996